Private Equity

Healthcare

PE-backed Young Innovations buys Crystal Dips

Young Innovations, a portfolio company of The Jordan Company, has acquired Irvine, California-based Crystal Tips, a supplier of disposable air/water syringe tips and adapters. No financial terms were disclosed.

2 min read · 01 May 2019

Gauge recruits Dennis as MD

Gauge Capital has named Stan Dennis as managing director. In his new role, Dennis will help lead the firm's healthcare investment strategy. Dennis is a former operating partner at Welsh, Carson, Anderson and Stowe.

2 min read · 30 April 2019

Vividion Therapeutics raises $82 mln

Vividion Therapeutics said April 30 that it raised $82 million in Series B financing led by Nextech Invest. New investors BVF Partners, Casdin Capital, Mubadala Ventures, Trinitas Capital, Mirae Asset Capital, Altitude Life Science Ventures, and Alexandria Venture Investments participated in the round. Existing investors ARCH Venture Partners, Versant Ventures, Cardinal Partners and Celgene Corp also took part. Vividion is a biotech that is developing discover small molecule therapeutics against biologically compelling but previously intractable targets.

3 min read · 30 April 2019

Ablacon raises $21.5 mln

Ablacon Inc said April 30 that it raised $21.5 million in a Series A round led by Ajax Health. Ablacon, of Wheat Ridge, Colorado, has developed an advanced mapping system to guide the treatment of atrial fibrillation.

3 min read · 30 April 2019

Blue Wolf, Macquarie approach deal for RHA Health

2 min read · 29 April 2019

PE-backed Canopy Biosciences buys Zellkraftwerk

Canopy Biosciences, which is backed by Ampersand Capital Partners, has acquired Zellkraftwerk, a German provider of cellular biomarkers. No financial terms were disclosed.

4 min read · 29 April 2019

Blue Wolf and Peloton to launch ClearSky Health

Blue Wolf Capital Partners LLC and Peloton Equity LLC have agreed to launch Austin-based ClearSky Health, which will develop and acquire inpatient rehabilitation facilities and related post-acute services companies. No financial terms were disclosed.

4 min read · 29 April 2019

Pharmaceutical Product Development to pay $1.35 bln dividend to sponsors: Bloomberg

Hellman & Friedman LLC and Carlyle Group LP are looking to take a $1.35 billion dividend out of Pharmaceutical Product Development LLC, Bloomberg is reporting. To fund the payment PPD is looking to sell a risky type of junk bond called PIK toggle that allows a borrower to delay interest payments, the story said.

1 min read · 29 April 2019

EMV Capital takes controlling stake in Vortex Biosciences

EMV Capital has acquired a controlling stake in Vortex Biosciences, a provider of liquid biopsy of circulating tumor cells. No financial terms were disclosed.

4 min read · 26 April 2019

BV invests in Franco Signor

BV Investment Partners has made an investment in Brandenton, Florida-based Franco Signor, a provider of medicare secondary payer compliance solutions. No financial terms were disclosed. JMP Securities LLC was financial adviser to Franco Signor on the deal.

3 min read · 25 April 2019

Showing 4,571 to 4,580 of 5,655 results
1…457459…566